Expert Information

This article explores what Medicare covers, with a special note about long-term care and assisted living.

Doctors who prescribe Leqembi, a new FDA-approved Alzheimer’s disease drug, are required to enroll their patients in a registry to obtain Medicare insurance coverage. Here are six facts to know about patient registries, including how your privacy is protected. 

Learn helpful caregiver tips for the holiday season.

Leqembi, an amyloid-clearing drug that's received full approval from the FDA, is offering renewed hope to people with early signs of dementia. Here’s what to know about it.

New research has shed light on the connection between ADHD and Alzheimer’s, including a first-of-its-kind study that suggests people who had ADHD as children may be more likely to develop Alzheimer’s as adults.

Some medications can cause memory loss, confusion, or other  side effects similar to dementia symptoms. See a list of drugs that may lead to misdiagnosis.

Researchers, including BrightFocus grantees, have been examining how modifiable lifestyle interventions such as intermittent fasting, the “fasting-mimicking” diet (FMD), ketone supplementation, and other targeted diet changes can help people delay Alzheimer’s disease, improve cognition, and live longer.

Neurodegenerative diseases such as Alzheimer’s, macular degeneration, and glaucoma commonly occur with age. Learn about what causes neurodegeneration, how to reduce your risk, and how researchers are exploring common pathways to find a cure faster. 

Learn about a recent study that is raising interest into whether a simple daily multivitamin can help improve memory, cognition, and brain function in the hope of delaying Alzheimer’s disease and related dementia.

In the U.S., Alzheimer’s screening blood tests are now available as another tool that can provide highly accurate, direct evidence of amyloid buildup in the brain earlier and faster than before.